Erratum: A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment
Sci Rep
.
2016 Oct 14:6:35509.
doi: 10.1038/srep35509.
Authors
F Du
,
P Yuan
,
Z T Zhao
,
Z Yang
,
T Wang
,
J D Zhao
,
Y Luo
,
F Ma
,
J Y Wang
,
Y Fan
,
R G Cai
,
P Zhang
,
Q Li
,
Y M Song
,
B H Xu
PMID:
27739502
PMCID:
PMC5064373
DOI:
10.1038/srep35509
No abstract available
Publication types
Published Erratum